Refine
Has Fulltext
- yes (8)
Is part of the Bibliography
- yes (8)
Document Type
- Journal article (7)
- Conference Proceeding (1)
Language
- English (8)
Keywords
- CXCR4 (4)
- PET (4)
- theranostics (4)
- endoradiotherapy (3)
- 18F-FDG (2)
- C-X-C motif chemokine receptor 4 (2)
- TKI (2)
- [68Ga]PentixaFor (2)
- adrenocortical carcinoma (2)
- positron emission tomography (2)
- vandetanib (2)
- 2-deoxy-2-(18F)fluoro-D-glucose (1)
- <sup>18</sup>F-FDG (1)
- <sup>68</sup>Ga-Pentixafor (1)
- IMAZA (1)
- NEC (1)
- NET (1)
- Positronen-Emissions-Tomografie (1)
- [177Lu]/[90Y]PentixaTher (1)
- [177Lu]PentixaTher (1)
- [90Y]PentixaTher (1)
- [\(^{68}\)Ga] pentixafor (1)
- combination (1)
- medullary thyroid carcinoma (1)
- multiple myeloma (1)
- papillary thyroid carcinoma (PTC) (1)
- personalized medicine (1)
- pleural mesothelioma (1)
- radioiodine (1)
- selpercatinib (1)
- thyroid carcinoma (TC) (1)
- tyrosine kinase inhibitor (1)
Institute
- Medizinische Klinik und Poliklinik I (8) (remove)
Sonstige beteiligte Institutionen
EU-Project number / Contract (GA) number
- 701983 (2)
Background
CXCR4-directed positron emission tomography/computed tomography (PET/CT) has been used as a diagnostic tool in patients with solid tumors. We aimed to determine a potential correlation between tumor burden and radiotracer accumulation in normal organs.
Methods
Ninety patients with histologically proven solid cancers underwent CXCR4-targeted [\(^{68}\)Ga]Ga-PentixaFor PET/CT. Volumes of interest (VOIs) were placed in normal organs (heart, liver, spleen, bone marrow, and kidneys) and tumor lesions. Mean standardized uptake values (SUV\(_{mean}\)) for normal organs were determined. For CXCR4-positive tumor burden, maximum SUV (SUV\(_{max}\)), tumor volume (TV), and fractional tumor activity (FTA, defined as SUV\(_{mean}\) x TV), were calculated. We used a Spearman's rank correlation coefficient (ρ) to derive correlative indices between normal organ uptake and tumor burden.
Results
Median SUV\(_{mean}\) in unaffected organs was 5.2 for the spleen (range, 2.44 – 10.55), 3.27 for the kidneys (range, 1.52 – 17.4), followed by bone marrow (1.76, range, 0.84 – 3.98), heart (1.66, range, 0.88 – 2.89), and liver (1.28, range, 0.73 – 2.45). No significant correlation between SUV\(_{max}\) in tumor lesions (ρ ≤ 0.189, P ≥ 0.07), TV (ρ ≥ -0.204, P ≥ 0.06) or FTA (ρ ≥ -0.142, P ≥ 0.18) with the investigated organs was found.
Conclusions
In patients with solid tumors imaged with [\(^{68}\)Ga]Ga-PentixaFor PET/CT, no relevant tumor sink effect was noted. This observation may be of relevance for therapies with radioactive and non-radioactive CXCR4-directed drugs, as with increasing tumor burden, the dose to normal organs may remain unchanged.